As of 2026-09-17, the Fair Value of Arecor Therapeutics PLC (AREC.L) is -130.19 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 85.50 GBP, the upside of Arecor Therapeutics PLC is -252.27%.
With the market price of 85.50 GBP and our fair value calculation, Arecor Therapeutics PLC (AREC.L) is not a good investment. Investing in AREC.L stocks now will result in a potential loss of 252.27%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -6.17 | -9.26 | -8.55 | -10.24 | 0.66 | -6.71 |
| YoY growth | -124.13% | -50.11% | 7.62% | -19.66% | 106.49% | -15.96% |
| Market Cap (mil) | 26.61 |
| P/E | |
| Forward P/E | 38.63x |
| EPS | -26.04 |
| Avg earnings growth rate | -15.96% |
| TTM earnings | -8.10 |